Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease-Reference-Cited by-同舟云学术

Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease

Published:2003-04-08 Issue:13 Volume:107 Page:1733-1737
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Vakkilainen Juha¹,Steiner George¹,Ansquer Jean-Claude¹,Aubin Francois¹,Rattier Stephanie¹,Foucher Christelle¹,Hamsten Anders¹,Taskinen Marja-Riitta¹

Affiliation:

1. From the Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland (J.V., M.-R.T.); the University Health Network, Toronto, Canada (G.S.); Laboratories Fournier, Daix, France (J.-C.A., F.A., S.R., C.F.); and the Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Hospital, Stockholm, Sweden (A.H.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes

2. Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

3. A Prospective Study of Triglyceride Level, Low-Density Lipoprotein Particle Diameter, and Risk of Myocardial Infarction

4. Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and harms of fibrate therapy in patients with type 2 diabetes: a systematic review and meta-analysis;Endocrine;2023-05-29

2. Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia;Journal of Clinical Medicine;2023-02-09

3. Fibrate Therapy: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes Mellitus Type 2;Contemporary Diabetes;2023

4. Interaction effect between fasting plasma glucose and lipid profiles on mortality of peritoneal dialysis patients;Clinical Kidney Journal;2022-12-15

5. A nano-enabled biotinylated anti-LDL theranostic system to modulate systemic LDL cholesterol;International Journal of Pharmaceutics;2022-11